Robert Lufkin MD: SAGE: A Self Administered Cognitive Assessment

The Self-Administered Gerocognitive Examination (SAGE) serves as a critical tool for establishing a cognitive baseline and detecting early signs of Alzheimer’s, metabolic dysfunction, and inflammation years before clinical diagnosis. Developed by neurologist Douglas Scharre at Ohio State University, this 15-minute paper-and-pencil test distinguishes itself from the Montreal Cognitive Assessment (MoCA) by being specifically designed for self-administration without a third party. The assessment evaluates memory, reasoning, and spatial skills through exercises such as naming animals, performing mental arithmetic, and drawing complex 3D structures or clock faces. While a score of 17 out of 22 is considered normal, the test functions as a screening mechanism rather than a definitive diagnosis. Regular monitoring via the four interchangeable versions of the exam allows individuals to track cognitive changes over time, facilitating medical intervention before significant neurological damage occurs.